Gain Therapeutics (GANX) Other Working Capital Changes (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly Other Working Capital Changes of $278213.0 for Q1 2026, up 275.22% year-over-year from $74145.9 in Q1 2025, and up 169.14% quarter-over-quarter from -$402385.0 in Q4 2025.
Gain Therapeutics (GANX) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Gain Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $278213.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 15.25% year-over-year to -$26710.0; the TTM figure through Mar 2026 stood at -$18894.0 (changed N/A YoY), while the FY2025 annual figure was -$130568.0, down 6.23% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$26710.0, down from -$23176.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was -$23176.0 in Q1 2025, with the low at -$26710.0 in Q1 2026.
- The 5-year median for Other Working Capital Changes is -$362298.0 (2024), against an average of $45682.9.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes tumbled 207.79% in 2022, then soared 42082.74% in 2024.
- Gain Therapeutics' Other Working Capital Changes stood at -$23176.0 in 2025, then dropped by 15.25% to -$26710.0 in 2026.
- Business Quant data shows GANX's Other Working Capital Changes at -$26710.0 in Q1 2026, -$23176.0 in Q1 2025, and $22907.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Gain Therapeutics | 86.61 Mn | 86.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 215,108.00 |
| Jun 30, 2026 | 215,108.00 |
| Jun 30, 2026 | 215,108.00 |
| Mar 31, 2026 | 278,213.00 |
| Mar 31, 2026 | 278,213.00 |
| Mar 31, 2026 | 278,213.00 |
| Dec 31, 2025 | -402,385.00 |
| Dec 31, 2025 | -402,385.00 |
| Dec 31, 2025 | -402,385.00 |
| Sep 30, 2025 | -768,436.00 |
| Sep 30, 2025 | -768,436.00 |
| Sep 30, 2025 | -768,436.00 |
| Jun 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | -158,776.00 |
| Mar 31, 2025 | -158,776.00 |
| Mar 31, 2025 | -158,776.00 |
| Dec 31, 2024 | -362,298.00 |
| Dec 31, 2024 | -362,298.00 |